952.2K NSE+BSE Volume
NSE 13 Mar, 2025 3:31 PM (IST)
SEBI Notice
Kaynes' MD, Ramesh Kunhikannan, gets a SEBI notice over SDD violations for Q4FY23 results
See details
High Financial Strength
Expensive Valuation
Technically Neutral
Expensive Performer
These stocks are strong in quality but with mid-range technical aspects. Their strong financials make them little expensive so choose the right moment to buy them.
View Similar
Embed DVM
Kaynes Technology Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..